You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR CITALOPRAM HYDROBROMIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for CITALOPRAM HYDROBROMIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00086645 ↗ Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1) Completed National Institute of Mental Health (NIMH) Phase 2 2004-04-01 This study will determine the efficacy and safety of citalopram compared to placebo in the treatment of children with autism.
NCT00086645 ↗ Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1) Completed Boston University Phase 2 2004-04-01 This study will determine the efficacy and safety of citalopram compared to placebo in the treatment of children with autism.
NCT00222820 ↗ Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study Completed Mental Health Intervention Research Center (MHIRC) Phase 4 2002-04-01 We are doing this pilot study to learn more about four aspects of treating depression: 1. The features of a depressed person's mood and anxiety and how these features affect a person's capacity to get better and stay better. 2. If depressed people with certain features of mood and anxiety respond better to therapy, medication or a combination of therapy and medication. 3. Whether or not a person's personality traits affect how they respond to treatment. 4. The gene involved in processing antidepressant medication
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for CITALOPRAM HYDROBROMIDE

Condition Name

Condition Name for CITALOPRAM HYDROBROMIDE
Intervention Trials
Healthy 5
Breast Cancer 2
Depression 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for CITALOPRAM HYDROBROMIDE
Intervention Trials
Depression 4
Depressive Disorder 3
Hot Flashes 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for CITALOPRAM HYDROBROMIDE

Trials by Country

Trials by Country for CITALOPRAM HYDROBROMIDE
Location Trials
United States 46
Canada 2
India 2
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for CITALOPRAM HYDROBROMIDE
Location Trials
Pennsylvania 3
Georgia 2
North Carolina 2
New York 2
California 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for CITALOPRAM HYDROBROMIDE

Clinical Trial Phase

Clinical Trial Phase for CITALOPRAM HYDROBROMIDE
Clinical Trial Phase Trials
Phase 4 1
Phase 3 2
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for CITALOPRAM HYDROBROMIDE
Clinical Trial Phase Trials
Completed 9
Active, not recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CITALOPRAM HYDROBROMIDE

Sponsor Name

Sponsor Name for CITALOPRAM HYDROBROMIDE
Sponsor Trials
Dr. Reddy's Laboratories Limited 2
National Institute of Mental Health (NIMH) 2
University of Pittsburgh 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for CITALOPRAM HYDROBROMIDE
Sponsor Trials
Other 8
Industry 6
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.